EHC Stock Analysis: Buy, Sell, or Hold?
EHC - Encompass Health Corporation Common Stock
$107.30
-0.19 (-0.18%)
▼
5d:
+0.14%
30d:
+1.96%
90d:
-4.25%
BUY
HIGH Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: Apr 30, 2026
0d
Get Alerted When EHC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: EHC shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: EHC shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$150.57
Based on 6.5% avg growth
INTRINSIC VALUE TODAY
$93.49
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: EHC is currently trading at $107.30, which is considered slightly high relative to its 30-day fair value range of $102.84 to $107.51. The stock's valuation (Forward PE: 16.4) is in line with its historical norms (16.9). Remarkably, the market is currently pricing in an annual earnings decline of 0.9% over the next few years. This pessimistic expectation contrasts with the company's recent 30.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, EHC is showing sideways momentum. The price is approaching resistance at $109.89. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: EHC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $140.64 (+31.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, EHC is showing sideways momentum. The price is approaching resistance at $109.89. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: EHC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $140.64 (+31.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$102.84 -
$107.51
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
76.2%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 31.1% below Wall St target ($140.64)
Trading Range Analysis
30-Day Trading Range
$102.84 -
$107.51
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$101.38
Resistance Level
$109.89
Current Trend
Sideways
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.45
Wall Street Target
$140.64
(+31.1%)
Revenue Growth (YoY)
9.0%
Earnings Growth (YoY)
30.3%
Profit Margin
10.0%
Valuation Discount vs History
-0.9% cheaper
PE vs Historical
16.5 vs 16.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.9%
(market-implied from PE analysis)
1-Year Target
$106.33
(-1%)
2-Year Target
$105.38
(-2%)
3-Year Target
$104.43
(-3%)
3-Yr Target (if PE normalizes)
(PE: 16→17)
$107.28
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 8.9%)
$185.70
(+73%)
Base:
(SPY PE: 16.5, Growth: 8.9%)
$138.60
(+29%)
Bear:
(PE: 14.0, Growth: 8.9%)
$117.81
(+10%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (18x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Trailing PE: 18.41 | Current EPS (TTM): $5.84
Bull Case
$132.06
(+23%)
Analyst growth 11.7%, PE expands to 20.3
Base Case
$120.05
(+12%)
Market implied 11.7%, PE stable at 18.4
Bear Case
$73.09
(-32%)
Severe decline -20.0%, PE contracts to 15.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 16.5 to 16.9
Stabilization Target:
$110.23
(+2.7%)
PE Expansion Potential:
+2.7%
Share & Embed Analysis
Last updated: May 14, 2026 11:35 PM ET
Data refreshes hourly during market hours. Next update: 12:35 AM
Data refreshes hourly during market hours. Next update: 12:35 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EHC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Edmund Fay
SELL
11937 shares
2026-03-09
Mark J Tarr
SELL
150000 shares
2026-02-11
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$513 | 66 BUY |
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$246 | 59 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$21 | 63 BUY |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$30 | 62 BUY |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 56 HOLD |
